nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—CYP2C19—Vismodegib—skin cancer	0.191	0.367	CbGbCtD
Tapentadol—CYP2C9—Vismodegib—skin cancer	0.159	0.305	CbGbCtD
Tapentadol—CYP2D6—Vemurafenib—skin cancer	0.115	0.22	CbGbCtD
Tapentadol—CYP2C9—Fluorouracil—skin cancer	0.0564	0.108	CbGbCtD
Tapentadol—Aspartate aminotransferase increased—Temozolomide—skin cancer	0.00174	0.00363	CcSEcCtD
Tapentadol—Hypotension—Vemurafenib—skin cancer	0.00174	0.00362	CcSEcCtD
Tapentadol—Palpitations—Imiquimod—skin cancer	0.00171	0.00358	CcSEcCtD
Tapentadol—Loss of consciousness—Imiquimod—skin cancer	0.00171	0.00356	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Temozolomide—skin cancer	0.0017	0.00356	CcSEcCtD
Tapentadol—Irritability—Fluorouracil—skin cancer	0.0017	0.00355	CcSEcCtD
Tapentadol—Cough—Imiquimod—skin cancer	0.00169	0.00354	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00169	0.00353	CcSEcCtD
Tapentadol—Convulsion—Imiquimod—skin cancer	0.00168	0.00351	CcSEcCtD
Tapentadol—Ataxia—Fluorouracil—skin cancer	0.00167	0.00349	CcSEcCtD
Tapentadol—Arthralgia—Imiquimod—skin cancer	0.00165	0.00345	CcSEcCtD
Tapentadol—Anxiety—Imiquimod—skin cancer	0.00165	0.00344	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00164	0.00343	CcSEcCtD
Tapentadol—Dry mouth—Imiquimod—skin cancer	0.00162	0.00337	CcSEcCtD
Tapentadol—Decreased appetite—Vemurafenib—skin cancer	0.00161	0.00337	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Vemurafenib—skin cancer	0.0016	0.00335	CcSEcCtD
Tapentadol—Fatigue—Vemurafenib—skin cancer	0.0016	0.00334	CcSEcCtD
Tapentadol—Nasopharyngitis—Fluorouracil—skin cancer	0.00159	0.00332	CcSEcCtD
Tapentadol—Constipation—Vemurafenib—skin cancer	0.00159	0.00332	CcSEcCtD
Tapentadol—Oedema—Imiquimod—skin cancer	0.00158	0.00331	CcSEcCtD
Tapentadol—Hypoaesthesia—Bleomycin—skin cancer	0.00158	0.00329	CcSEcCtD
Tapentadol—Infection—Imiquimod—skin cancer	0.00157	0.00329	CcSEcCtD
Tapentadol—Shock—Imiquimod—skin cancer	0.00156	0.00325	CcSEcCtD
Tapentadol—Nervous system disorder—Imiquimod—skin cancer	0.00155	0.00324	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Temozolomide—skin cancer	0.00155	0.00324	CcSEcCtD
Tapentadol—Tachycardia—Imiquimod—skin cancer	0.00155	0.00323	CcSEcCtD
Tapentadol—Pollakiuria—Temozolomide—skin cancer	0.00154	0.00322	CcSEcCtD
Tapentadol—Skin disorder—Imiquimod—skin cancer	0.00154	0.00321	CcSEcCtD
Tapentadol—Erectile dysfunction—Temozolomide—skin cancer	0.00154	0.00321	CcSEcCtD
Tapentadol—Hyperhidrosis—Imiquimod—skin cancer	0.00153	0.0032	CcSEcCtD
Tapentadol—Weight decreased—Temozolomide—skin cancer	0.00151	0.00315	CcSEcCtD
Tapentadol—Infestation NOS—Temozolomide—skin cancer	0.00149	0.00311	CcSEcCtD
Tapentadol—Infestation—Temozolomide—skin cancer	0.00149	0.00311	CcSEcCtD
Tapentadol—Depression—Temozolomide—skin cancer	0.00148	0.0031	CcSEcCtD
Tapentadol—Urinary tract infection—Temozolomide—skin cancer	0.00145	0.00302	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00144	0.00301	CcSEcCtD
Tapentadol—Insomnia—Imiquimod—skin cancer	0.00143	0.00299	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Fluorouracil—skin cancer	0.00143	0.00299	CcSEcCtD
Tapentadol—Paraesthesia—Imiquimod—skin cancer	0.00142	0.00297	CcSEcCtD
Tapentadol—Chills—Bleomycin—skin cancer	0.00142	0.00297	CcSEcCtD
Tapentadol—Dyspnoea—Imiquimod—skin cancer	0.00141	0.00295	CcSEcCtD
Tapentadol—Somnolence—Imiquimod—skin cancer	0.00141	0.00294	CcSEcCtD
Tapentadol—Dyspepsia—Imiquimod—skin cancer	0.00139	0.00291	CcSEcCtD
Tapentadol—Decreased appetite—Imiquimod—skin cancer	0.00138	0.00288	CcSEcCtD
Tapentadol—Hot flush—Docetaxel—skin cancer	0.00137	0.00287	CcSEcCtD
Tapentadol—Infestation NOS—Fluorouracil—skin cancer	0.00137	0.00286	CcSEcCtD
Tapentadol—Infestation—Fluorouracil—skin cancer	0.00137	0.00286	CcSEcCtD
Tapentadol—Hypersensitivity—Vemurafenib—skin cancer	0.00137	0.00286	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Imiquimod—skin cancer	0.00137	0.00286	CcSEcCtD
Tapentadol—Fatigue—Imiquimod—skin cancer	0.00137	0.00285	CcSEcCtD
Tapentadol—Menopausal symptoms—Docetaxel—skin cancer	0.00136	0.00284	CcSEcCtD
Tapentadol—Visual disturbance—Docetaxel—skin cancer	0.00136	0.00283	CcSEcCtD
Tapentadol—Urinary tract infection—Fluorouracil—skin cancer	0.00133	0.00278	CcSEcCtD
Tapentadol—Asthenia—Vemurafenib—skin cancer	0.00133	0.00278	CcSEcCtD
Tapentadol—Hypoaesthesia—Temozolomide—skin cancer	0.00133	0.00278	CcSEcCtD
Tapentadol—Hallucination—Temozolomide—skin cancer	0.00133	0.00278	CcSEcCtD
Tapentadol—Chills—Dactinomycin—skin cancer	0.00133	0.00277	CcSEcCtD
Tapentadol—Urinary tract disorder—Temozolomide—skin cancer	0.00132	0.00276	CcSEcCtD
Tapentadol—Pruritus—Vemurafenib—skin cancer	0.00131	0.00274	CcSEcCtD
Tapentadol—Connective tissue disorder—Temozolomide—skin cancer	0.00131	0.00274	CcSEcCtD
Tapentadol—Lethargy—Docetaxel—skin cancer	0.00131	0.00274	CcSEcCtD
Tapentadol—Urethral disorder—Temozolomide—skin cancer	0.00131	0.00274	CcSEcCtD
Tapentadol—Feeling abnormal—Imiquimod—skin cancer	0.00131	0.00273	CcSEcCtD
Tapentadol—Visual impairment—Temozolomide—skin cancer	0.00129	0.00269	CcSEcCtD
Tapentadol—Diarrhoea—Vemurafenib—skin cancer	0.00127	0.00265	CcSEcCtD
Tapentadol—Urticaria—Imiquimod—skin cancer	0.00126	0.00263	CcSEcCtD
Tapentadol—Eye disorder—Temozolomide—skin cancer	0.00125	0.00261	CcSEcCtD
Tapentadol—Cardiac disorder—Temozolomide—skin cancer	0.00124	0.00259	CcSEcCtD
Tapentadol—Dizziness—Vemurafenib—skin cancer	0.00123	0.00256	CcSEcCtD
Tapentadol—Hypoaesthesia—Fluorouracil—skin cancer	0.00122	0.00256	CcSEcCtD
Tapentadol—Angiopathy—Temozolomide—skin cancer	0.00121	0.00253	CcSEcCtD
Tapentadol—Ataxia—Docetaxel—skin cancer	0.00121	0.00252	CcSEcCtD
Tapentadol—Immune system disorder—Temozolomide—skin cancer	0.00121	0.00252	CcSEcCtD
Tapentadol—Mediastinal disorder—Temozolomide—skin cancer	0.0012	0.00251	CcSEcCtD
Tapentadol—Cough—Bleomycin—skin cancer	0.0012	0.00251	CcSEcCtD
Tapentadol—Chills—Temozolomide—skin cancer	0.0012	0.0025	CcSEcCtD
Tapentadol—Vomiting—Vemurafenib—skin cancer	0.00118	0.00247	CcSEcCtD
Tapentadol—Rash—Vemurafenib—skin cancer	0.00117	0.00245	CcSEcCtD
Tapentadol—Mental disorder—Temozolomide—skin cancer	0.00117	0.00244	CcSEcCtD
Tapentadol—Dermatitis—Vemurafenib—skin cancer	0.00117	0.00244	CcSEcCtD
Tapentadol—Hypersensitivity—Imiquimod—skin cancer	0.00117	0.00244	CcSEcCtD
Tapentadol—Headache—Vemurafenib—skin cancer	0.00116	0.00243	CcSEcCtD
Tapentadol—Malnutrition—Temozolomide—skin cancer	0.00116	0.00243	CcSEcCtD
Tapentadol—Breast disorder—Docetaxel—skin cancer	0.00116	0.00242	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.00116	0.00242	CcSEcCtD
Tapentadol—Nasopharyngitis—Docetaxel—skin cancer	0.00115	0.0024	CcSEcCtD
Tapentadol—Asthenia—Imiquimod—skin cancer	0.00114	0.00237	CcSEcCtD
Tapentadol—Confusional state—Bleomycin—skin cancer	0.00113	0.00237	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Docetaxel—skin cancer	0.00113	0.00237	CcSEcCtD
Tapentadol—Oedema—Bleomycin—skin cancer	0.00113	0.00235	CcSEcCtD
Tapentadol—Anaphylactic shock—Bleomycin—skin cancer	0.00113	0.00235	CcSEcCtD
Tapentadol—Pruritus—Imiquimod—skin cancer	0.00112	0.00234	CcSEcCtD
Tapentadol—Infection—Bleomycin—skin cancer	0.00112	0.00233	CcSEcCtD
Tapentadol—Nausea—Vemurafenib—skin cancer	0.0011	0.0023	CcSEcCtD
Tapentadol—Vision blurred—Temozolomide—skin cancer	0.0011	0.00229	CcSEcCtD
Tapentadol—Tremor—Temozolomide—skin cancer	0.00109	0.00228	CcSEcCtD
Tapentadol—Diarrhoea—Imiquimod—skin cancer	0.00108	0.00226	CcSEcCtD
Tapentadol—Agitation—Temozolomide—skin cancer	0.00107	0.00223	CcSEcCtD
Tapentadol—Angioedema—Temozolomide—skin cancer	0.00106	0.00222	CcSEcCtD
Tapentadol—Hypotension—Bleomycin—skin cancer	0.00105	0.0022	CcSEcCtD
Tapentadol—Oedema—Dactinomycin—skin cancer	0.00105	0.00219	CcSEcCtD
Tapentadol—Dizziness—Imiquimod—skin cancer	0.00105	0.00219	CcSEcCtD
Tapentadol—Vertigo—Temozolomide—skin cancer	0.00104	0.00218	CcSEcCtD
Tapentadol—Infection—Dactinomycin—skin cancer	0.00104	0.00218	CcSEcCtD
Tapentadol—Palpitations—Temozolomide—skin cancer	0.00103	0.00215	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00103	0.00214	CcSEcCtD
Tapentadol—Cough—Temozolomide—skin cancer	0.00101	0.00212	CcSEcCtD
Tapentadol—Paraesthesia—Bleomycin—skin cancer	0.00101	0.00211	CcSEcCtD
Tapentadol—Vision blurred—Fluorouracil—skin cancer	0.00101	0.00211	CcSEcCtD
Tapentadol—Convulsion—Temozolomide—skin cancer	0.00101	0.0021	CcSEcCtD
Tapentadol—Vomiting—Imiquimod—skin cancer	0.00101	0.0021	CcSEcCtD
Tapentadol—Weight decreased—Docetaxel—skin cancer	0.001	0.0021	CcSEcCtD
Tapentadol—Dyspnoea—Bleomycin—skin cancer	0.001	0.0021	CcSEcCtD
Tapentadol—Rash—Imiquimod—skin cancer	0.000999	0.00209	CcSEcCtD
Tapentadol—Dermatitis—Imiquimod—skin cancer	0.000998	0.00208	CcSEcCtD
Tapentadol—Headache—Imiquimod—skin cancer	0.000992	0.00207	CcSEcCtD
Tapentadol—Arthralgia—Temozolomide—skin cancer	0.00099	0.00207	CcSEcCtD
Tapentadol—Infestation NOS—Docetaxel—skin cancer	0.00099	0.00207	CcSEcCtD
Tapentadol—Infestation—Docetaxel—skin cancer	0.00099	0.00207	CcSEcCtD
Tapentadol—Anxiety—Temozolomide—skin cancer	0.000987	0.00206	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000983	0.00205	CcSEcCtD
Tapentadol—Decreased appetite—Bleomycin—skin cancer	0.000978	0.00204	CcSEcCtD
Tapentadol—Dry mouth—Temozolomide—skin cancer	0.000968	0.00202	CcSEcCtD
Tapentadol—Confusional state—Temozolomide—skin cancer	0.000957	0.002	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000956	0.002	CcSEcCtD
Tapentadol—Anaphylactic shock—Temozolomide—skin cancer	0.000949	0.00198	CcSEcCtD
Tapentadol—Oedema—Temozolomide—skin cancer	0.000949	0.00198	CcSEcCtD
Tapentadol—Infection—Temozolomide—skin cancer	0.000943	0.00197	CcSEcCtD
Tapentadol—Nausea—Imiquimod—skin cancer	0.000941	0.00196	CcSEcCtD
Tapentadol—Nervous system disorder—Temozolomide—skin cancer	0.000931	0.00194	CcSEcCtD
Tapentadol—Convulsion—Fluorouracil—skin cancer	0.000928	0.00194	CcSEcCtD
Tapentadol—Feeling abnormal—Bleomycin—skin cancer	0.000927	0.00194	CcSEcCtD
Tapentadol—Skin disorder—Temozolomide—skin cancer	0.000922	0.00193	CcSEcCtD
Tapentadol—Hyperhidrosis—Temozolomide—skin cancer	0.000918	0.00192	CcSEcCtD
Tapentadol—Decreased appetite—Dactinomycin—skin cancer	0.000912	0.00191	CcSEcCtD
Tapentadol—Fatigue—Dactinomycin—skin cancer	0.000905	0.00189	CcSEcCtD
Tapentadol—Urticaria—Bleomycin—skin cancer	0.000894	0.00187	CcSEcCtD
Tapentadol—Hypoaesthesia—Docetaxel—skin cancer	0.000884	0.00185	CcSEcCtD
Tapentadol—Confusional state—Fluorouracil—skin cancer	0.000882	0.00184	CcSEcCtD
Tapentadol—Urinary tract disorder—Docetaxel—skin cancer	0.000877	0.00183	CcSEcCtD
Tapentadol—Anaphylactic shock—Fluorouracil—skin cancer	0.000874	0.00183	CcSEcCtD
Tapentadol—Oedema—Fluorouracil—skin cancer	0.000874	0.00183	CcSEcCtD
Tapentadol—Connective tissue disorder—Docetaxel—skin cancer	0.000873	0.00182	CcSEcCtD
Tapentadol—Urethral disorder—Docetaxel—skin cancer	0.000871	0.00182	CcSEcCtD
Tapentadol—Infection—Fluorouracil—skin cancer	0.000869	0.00181	CcSEcCtD
Tapentadol—Feeling abnormal—Dactinomycin—skin cancer	0.000865	0.00181	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000865	0.00181	CcSEcCtD
Tapentadol—Insomnia—Temozolomide—skin cancer	0.000858	0.00179	CcSEcCtD
Tapentadol—Nervous system disorder—Fluorouracil—skin cancer	0.000858	0.00179	CcSEcCtD
Tapentadol—Visual impairment—Docetaxel—skin cancer	0.000856	0.00179	CcSEcCtD
Tapentadol—Tachycardia—Fluorouracil—skin cancer	0.000853	0.00178	CcSEcCtD
Tapentadol—Paraesthesia—Temozolomide—skin cancer	0.000852	0.00178	CcSEcCtD
Tapentadol—Dyspnoea—Temozolomide—skin cancer	0.000846	0.00177	CcSEcCtD
Tapentadol—Somnolence—Temozolomide—skin cancer	0.000844	0.00176	CcSEcCtD
Tapentadol—Dyspepsia—Temozolomide—skin cancer	0.000835	0.00174	CcSEcCtD
Tapentadol—Eye disorder—Docetaxel—skin cancer	0.00083	0.00173	CcSEcCtD
Tapentadol—Hypersensitivity—Bleomycin—skin cancer	0.000829	0.00173	CcSEcCtD
Tapentadol—Decreased appetite—Temozolomide—skin cancer	0.000825	0.00172	CcSEcCtD
Tapentadol—Cardiac disorder—Docetaxel—skin cancer	0.000824	0.00172	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Temozolomide—skin cancer	0.000819	0.00171	CcSEcCtD
Tapentadol—Fatigue—Temozolomide—skin cancer	0.000818	0.00171	CcSEcCtD
Tapentadol—Hypotension—Fluorouracil—skin cancer	0.000817	0.00171	CcSEcCtD
Tapentadol—Constipation—Temozolomide—skin cancer	0.000812	0.0017	CcSEcCtD
Tapentadol—Asthenia—Bleomycin—skin cancer	0.000807	0.00169	CcSEcCtD
Tapentadol—Angiopathy—Docetaxel—skin cancer	0.000806	0.00168	CcSEcCtD
Tapentadol—Immune system disorder—Docetaxel—skin cancer	0.000802	0.00168	CcSEcCtD
Tapentadol—Mediastinal disorder—Docetaxel—skin cancer	0.000801	0.00167	CcSEcCtD
Tapentadol—Chills—Docetaxel—skin cancer	0.000797	0.00166	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000797	0.00166	CcSEcCtD
Tapentadol—Pruritus—Bleomycin—skin cancer	0.000796	0.00166	CcSEcCtD
Tapentadol—Insomnia—Fluorouracil—skin cancer	0.000791	0.00165	CcSEcCtD
Tapentadol—Paraesthesia—Fluorouracil—skin cancer	0.000785	0.00164	CcSEcCtD
Tapentadol—Feeling abnormal—Temozolomide—skin cancer	0.000782	0.00163	CcSEcCtD
Tapentadol—Dyspnoea—Fluorouracil—skin cancer	0.00078	0.00163	CcSEcCtD
Tapentadol—Mental disorder—Docetaxel—skin cancer	0.000778	0.00163	CcSEcCtD
Tapentadol—Somnolence—Fluorouracil—skin cancer	0.000777	0.00162	CcSEcCtD
Tapentadol—Malnutrition—Docetaxel—skin cancer	0.000773	0.00162	CcSEcCtD
Tapentadol—Hypersensitivity—Dactinomycin—skin cancer	0.000773	0.00161	CcSEcCtD
Tapentadol—Dyspepsia—Fluorouracil—skin cancer	0.00077	0.00161	CcSEcCtD
Tapentadol—Decreased appetite—Fluorouracil—skin cancer	0.00076	0.00159	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000755	0.00158	CcSEcCtD
Tapentadol—Urticaria—Temozolomide—skin cancer	0.000754	0.00157	CcSEcCtD
Tapentadol—Asthenia—Dactinomycin—skin cancer	0.000753	0.00157	CcSEcCtD
Tapentadol—Feeling abnormal—Fluorouracil—skin cancer	0.000721	0.00151	CcSEcCtD
Tapentadol—Diarrhoea—Dactinomycin—skin cancer	0.000718	0.0015	CcSEcCtD
Tapentadol—Vomiting—Bleomycin—skin cancer	0.000715	0.00149	CcSEcCtD
Tapentadol—Rash—Bleomycin—skin cancer	0.000709	0.00148	CcSEcCtD
Tapentadol—Dermatitis—Bleomycin—skin cancer	0.000709	0.00148	CcSEcCtD
Tapentadol—Hypersensitivity—Temozolomide—skin cancer	0.000699	0.00146	CcSEcCtD
Tapentadol—Urticaria—Fluorouracil—skin cancer	0.000695	0.00145	CcSEcCtD
Tapentadol—Syncope—Docetaxel—skin cancer	0.000694	0.00145	CcSEcCtD
Tapentadol—Palpitations—Docetaxel—skin cancer	0.000683	0.00143	CcSEcCtD
Tapentadol—Asthenia—Temozolomide—skin cancer	0.000681	0.00142	CcSEcCtD
Tapentadol—Loss of consciousness—Docetaxel—skin cancer	0.00068	0.00142	CcSEcCtD
Tapentadol—Cough—Docetaxel—skin cancer	0.000675	0.00141	CcSEcCtD
Tapentadol—Pruritus—Temozolomide—skin cancer	0.000671	0.0014	CcSEcCtD
Tapentadol—Convulsion—Docetaxel—skin cancer	0.00067	0.0014	CcSEcCtD
Tapentadol—Nausea—Bleomycin—skin cancer	0.000668	0.0014	CcSEcCtD
Tapentadol—Vomiting—Dactinomycin—skin cancer	0.000667	0.00139	CcSEcCtD
Tapentadol—Rash—Dactinomycin—skin cancer	0.000662	0.00138	CcSEcCtD
Tapentadol—Arthralgia—Docetaxel—skin cancer	0.000658	0.00138	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000654	0.00137	CcSEcCtD
Tapentadol—Diarrhoea—Temozolomide—skin cancer	0.000649	0.00136	CcSEcCtD
Tapentadol—Hypersensitivity—Fluorouracil—skin cancer	0.000644	0.00135	CcSEcCtD
Tapentadol—Dry mouth—Docetaxel—skin cancer	0.000644	0.00134	CcSEcCtD
Tapentadol—Confusional state—Docetaxel—skin cancer	0.000636	0.00133	CcSEcCtD
Tapentadol—Anaphylactic shock—Docetaxel—skin cancer	0.000631	0.00132	CcSEcCtD
Tapentadol—Oedema—Docetaxel—skin cancer	0.000631	0.00132	CcSEcCtD
Tapentadol—Dizziness—Temozolomide—skin cancer	0.000628	0.00131	CcSEcCtD
Tapentadol—Infection—Docetaxel—skin cancer	0.000627	0.00131	CcSEcCtD
Tapentadol—Nausea—Dactinomycin—skin cancer	0.000623	0.0013	CcSEcCtD
Tapentadol—Shock—Docetaxel—skin cancer	0.000621	0.0013	CcSEcCtD
Tapentadol—Nervous system disorder—Docetaxel—skin cancer	0.000619	0.00129	CcSEcCtD
Tapentadol—Pruritus—Fluorouracil—skin cancer	0.000619	0.00129	CcSEcCtD
Tapentadol—Tachycardia—Docetaxel—skin cancer	0.000616	0.00129	CcSEcCtD
Tapentadol—Skin disorder—Docetaxel—skin cancer	0.000613	0.00128	CcSEcCtD
Tapentadol—Vomiting—Temozolomide—skin cancer	0.000603	0.00126	CcSEcCtD
Tapentadol—Rash—Temozolomide—skin cancer	0.000598	0.00125	CcSEcCtD
Tapentadol—Diarrhoea—Fluorouracil—skin cancer	0.000598	0.00125	CcSEcCtD
Tapentadol—Dermatitis—Temozolomide—skin cancer	0.000598	0.00125	CcSEcCtD
Tapentadol—Headache—Temozolomide—skin cancer	0.000595	0.00124	CcSEcCtD
Tapentadol—Hypotension—Docetaxel—skin cancer	0.00059	0.00123	CcSEcCtD
Tapentadol—Dizziness—Fluorouracil—skin cancer	0.000578	0.00121	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000575	0.0012	CcSEcCtD
Tapentadol—Insomnia—Docetaxel—skin cancer	0.000571	0.00119	CcSEcCtD
Tapentadol—Paraesthesia—Docetaxel—skin cancer	0.000567	0.00118	CcSEcCtD
Tapentadol—Nausea—Temozolomide—skin cancer	0.000564	0.00118	CcSEcCtD
Tapentadol—Dyspnoea—Docetaxel—skin cancer	0.000563	0.00118	CcSEcCtD
Tapentadol—Somnolence—Docetaxel—skin cancer	0.000561	0.00117	CcSEcCtD
Tapentadol—Vomiting—Fluorouracil—skin cancer	0.000556	0.00116	CcSEcCtD
Tapentadol—Dyspepsia—Docetaxel—skin cancer	0.000556	0.00116	CcSEcCtD
Tapentadol—Rash—Fluorouracil—skin cancer	0.000551	0.00115	CcSEcCtD
Tapentadol—Dermatitis—Fluorouracil—skin cancer	0.000551	0.00115	CcSEcCtD
Tapentadol—Decreased appetite—Docetaxel—skin cancer	0.000549	0.00115	CcSEcCtD
Tapentadol—Headache—Fluorouracil—skin cancer	0.000548	0.00114	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Docetaxel—skin cancer	0.000545	0.00114	CcSEcCtD
Tapentadol—Fatigue—Docetaxel—skin cancer	0.000544	0.00114	CcSEcCtD
Tapentadol—Constipation—Docetaxel—skin cancer	0.00054	0.00113	CcSEcCtD
Tapentadol—Feeling abnormal—Docetaxel—skin cancer	0.00052	0.00109	CcSEcCtD
Tapentadol—Nausea—Fluorouracil—skin cancer	0.000519	0.00108	CcSEcCtD
Tapentadol—Hypersensitivity—Docetaxel—skin cancer	0.000465	0.000971	CcSEcCtD
Tapentadol—Asthenia—Docetaxel—skin cancer	0.000453	0.000946	CcSEcCtD
Tapentadol—Pruritus—Docetaxel—skin cancer	0.000447	0.000933	CcSEcCtD
Tapentadol—Diarrhoea—Docetaxel—skin cancer	0.000432	0.000902	CcSEcCtD
Tapentadol—Dizziness—Docetaxel—skin cancer	0.000417	0.000872	CcSEcCtD
Tapentadol—Vomiting—Docetaxel—skin cancer	0.000401	0.000838	CcSEcCtD
Tapentadol—Rash—Docetaxel—skin cancer	0.000398	0.000831	CcSEcCtD
Tapentadol—Dermatitis—Docetaxel—skin cancer	0.000398	0.00083	CcSEcCtD
Tapentadol—Headache—Docetaxel—skin cancer	0.000395	0.000826	CcSEcCtD
Tapentadol—Nausea—Docetaxel—skin cancer	0.000375	0.000783	CcSEcCtD
